HKD 3.08
(-2.53%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 445.4 Million HKD | -38.05% |
2022 | 718.95 Million HKD | 15.92% |
2021 | 620.2 Million HKD | 88.24% |
2020 | 329.47 Million HKD | 32.85% |
2019 | 248 Million HKD | -6.25% |
2018 | 264.54 Million HKD | 121.13% |
2017 | 119.63 Million HKD | 189.54% |
2016 | 41.31 Million HKD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 468.15 Million HKD | 0.0% |
2023 FY | 445.4 Million HKD | -38.05% |
2023 Q2 | 801.01 Million HKD | 0.0% |
2023 Q4 | 445.4 Million HKD | 0.0% |
2022 FY | 718.95 Million HKD | 15.92% |
2022 Q4 | 718.95 Million HKD | 0.0% |
2022 Q2 | 650.68 Million HKD | 0.0% |
2021 Q2 | 411.53 Million HKD | 0.0% |
2021 FY | 620.2 Million HKD | 88.24% |
2021 Q4 | 620.2 Million HKD | 0.0% |
2020 Q4 | 329.47 Million HKD | 0.0% |
2020 FY | 329.47 Million HKD | 32.85% |
2020 Q2 | 134.46 Million HKD | 0.0% |
2019 FY | 248 Million HKD | -6.25% |
2019 Q2 | - HKD | 0.0% |
2019 Q4 | 248 Million HKD | 0.0% |
2018 FY | 264.54 Million HKD | 121.13% |
2017 FY | 119.63 Million HKD | 189.54% |
2016 FY | 41.31 Million HKD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
China Healthwise Holdings Limited | 145.27 Million HKD | -206.601% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 413.75 Million HKD | -7.649% |